Gender and cell-type-specific effects of the transcription-coupled repair protein, ERCC6/CSB, on repeat expansion in a mouse model of the fragile X-related disorders

Human Mutation

Volumn 35, Issue 3, 2014, Pages 341-349

  Zhao, Xiao Nan ^a   Usdin, Karen ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Ataxia; CSB; ERCC6; Fragile X related; Primary ovarian insufficiency; Repeat expansion; Transcription coupled repair

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; PROTEIN; TRANSCRIPTION COUPLED REPAIR PROTEIN CSB; TRANSCRIPTION COUPLED REPAIR PROTEIN ERCC6; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL SPECIFICITY; COCKAYNE SYNDROME GROUP B GENE; CONTROLLED STUDY; DNA REPAIR; FEMALE; FRAGILE X SYNDROME; GENE; GENE LOSS; GENE MUTATION; GENETIC TRANSCRIPTION; GENOMIC INSTABILITY; MALE; MOSAICISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; TANDEM REPEAT; TRANSCRIPTION COUPLED REPAIR;

ANIMALIA;

5' UNTRANSLATED REGIONS; ALLELES; ANIMALS; DISEASE MODELS, ANIMAL; DNA REPAIR; DNA REPAIR ENZYMES; DNA REPEAT EXPANSION; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; MALE; MICE; MICE, KNOCKOUT; RNA, MESSENGER; SEX FACTORS; TRANSCRIPTION, GENETIC;

EID: 84893945596     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.22495     Document Type: Article

References (58)

1. Aamann MD, Muftuoglu M, Bohr VA, Stevnsner T. 2013. Multiple interaction partners for Cockayne syndrome proteins: implications for genome and transcriptome maintenance. Mech Ageing Dev 134:212-224.
2. Araneda S, Pelloux S, Radicella JP, Angulo J, Kitahama K, Gysling K, Forray MI. 2005. 8-Oxoguanine DNA glycosylase, but not Kin17 protein, is translocated and differentially regulated by estrogens in rat brain cells. Neuroscience 136:135-146.
3. Berg RJ, Rebel H, van der Horst GT, van Kranen HJ, Mullenders LH, van Vloten WA, de Gruijl FR. 2000. Impact of global genome repair versus transcription-coupled repair on ultraviolet carcinogenesis in hairless mice. Cancer Res 60:2858-2863.
4. Berger CE, Qian Y, Liu G, Chen H, Chen X. 2012. p53, a target of estrogen receptor (ER) alpha, modulates DNA damage-induced growth suppression in ER-positive breast cancer cells. J Biol Chem 287:30117-30127.
5. Brouwer JR, Huizer K, Severijnen LA, Hukema RK, Berman RF, Oostra BA, Willemsen R. 2008. CGG-repeat length and neuropathological and molecular correlates in a mouse model for fragile X-associated tremor/ataxia syndrome. J Neurochem 107:1671-1682.
6. Cabanes A, Wang M, Olivo S, DeAssis S, Gustafsson JA, Khan G, Hilakivi-Clarke L. 2004. Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis. Carcinogenesis 25:741-748.
7. Dietrich AK, Humphreys GI, Nardulli AM. 2013. 17beta-Estradiol increases expression of the oxidative stress response and DNA repair protein apurinic endonuclease (Ape1) in the cerebral cortex of female mice following hypoxia. J Steroid Biochem Mol Biol 138:410-420.
8. Dragileva E, Hendricks A, Teed A, Gillis T, Lopez ET, Friedberg EC, Kucherlapati R, Edelmann W, Lunetta KL, MacDonald ME, Wheeler VC. 2009. Intergenerational and striatal CAG repeat instability in Huntington's disease knock-in mice involve different DNA repair genes. Neurobiol Dis 33:37-47.
9. Entezam A, Biacsi R, Orrison B, Saha T, Hoffman GE, Grabczyk E, Nussbaum RL, Usdin K. 2007. Regional FMRP deficits and large repeat expansions into the full mutation range in a new Fragile X premutation mouse model. Gene 395:125-134.
10. Entezam A, Lokanga AR, Le W, Hoffman G, Usdin K. 2010. Potassium bromate, a potent DNA oxidizing agent, exacerbates germline repeat expansion in a fragile X premutation mouse model. Hum Mutat 31:611-616.
11. Entezam A, Usdin K. 2008. ATR protects the genome against CGG.CCG-repeat expansion in Fragile X premutation mice. Nucleic Acids Res 36:1050-1056.
12. Entezam A, Usdin K. 2009. ATM and ATR protect the genome against two different types of tandem repeat instability in Fragile X premutation mice. Nucleic Acids Res 37:6371-6377.
13. Foiry L, Dong L, Savouret C, Hubert L, Riele H, Junien C, Gourdon G. 2006. Msh3 is a limiting factor in the formation of intergenerational CTG expansions in DM1 transgenic mice. Hum Genet 119:520-526.
14. Fu YH, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, Verkerk AJ, Holden JJ, Fenwick RG Jr., Warren ST, Oostra BA, Nelson DL, Caskey CT. 1991. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67:1047-1058.
15. Hagerman PJ, Hagerman RJ. 2004. Fragile X-associated tremor/ataxia syndrome (FXTAS). Ment Retard Dev Disabil Res Rev 10:25-30.
16. Halabi A, Ditch S, Wang J, Grabczyk E. 2012. DNA mismatch repair complex MutSbeta promotes GAA.TTC repeat expansion in human cells. J Biol Chem 287:29958-29967.
17. Hubert L Jr., Lin Y, Dion V, Wilson JH. 2011. Xpa deficiency reduces CAG trinucleotide repeat instability in neuronal tissues in a mouse model of SCA1. Hum Mol Genet 20:4822-4830.
18. Jin P, Lu XJ, Sheng JQ, Fu L, Meng XM, Wang X, Shi TP, Li SR, Rao J. 2010. Estrogen stimulates the expression of mismatch repair gene hMLH1 in colonic epithelial cells. Cancer Prev Res (Phila) 3:910-916.
19. Jung J, Bonini N. 2007. CREB-binding protein modulates repeat instability in a Drosophila model for polyQ disease. Science 315:1857-1859.
20. Kovtun IV, Johnson KO, McMurray CT. 2011. Cockayne syndrome B protein antagonizes OGG1 in modulating CAG repeat length in vivo. Aging (Albany NY) 3:509-514.
21. Kovtun IV, Therneau TM, McMurray CT. 2000. Gender of the embryo contributes to CAG instability in transgenic mice containing a Huntington's disease gene. Hum Mol Genet 9:2767-2775.
22. Lee JM, Zhang J, Su AI, Walker JR, Wiltshire T, Kang K, Dragileva E, Gillis T, Lopez ET, Boily MJ, Cyr M, Kohane I, et al. 2010. A novel approach to investigate tissue-specific trinucleotide repeat instability. BMC Syst Biol 4:29.
23. Likhite VS, Cass EI, Anderson SD, Yates JR, Nardulli AM. 2004. Interaction of estrogen receptor alpha with 3-methyladenine DNA glycosylase modulates transcription and DNA repair. J Biol Chem 279:16875-16882.
24. Lin Y, Hubert L Jr., Wilson JH. 2009. Transcription destabilizes triplet repeats. Mol Carcinog 48:350-361.
25. Lin Y, Wilson JH. 2007. Transcription-induced CAG repeat contraction in human cells is mediated in part by transcription-coupled nucleotide excision repair. Mol Cell Biol 27:6209-6217.
26. Lokanga RA, Entezam A, Kumari D, Yudkin D, Qin M, Smith CB, Usdin K. 2013a. Somatic expansion in mouse and human carriers of Fragile X premutation alleles. Hum Mutat 34:157-166.
27. Lokanga RA, Zhao X-N, Usdin K. 2013b. The mismatch repair protein, MSH2, is rate-limiting for repeat expansion in a Fragile X premutation mouse model. Hum Mutat. 35:129-136.
28. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP. 1996. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493-506.
29. Medunjanin S, Weinert S, Poitz D, Schmeisser A, Strasser RH, Braun-Dullaeus RC. 2010. Transcriptional activation of DNA-dependent protein kinase catalytic subunit gene expression by oestrogen receptor-alpha. EMBO Rep 11:208-213.
30. Menoni H, Hoeijmakers JH, Vermeulen W. 2012. Nucleotide excision repair-initiating proteins bind to oxidative DNA lesions in vivo. J Cell Biol 199:1037-1046.
31. Mirkin SM. 2006. DNA structures, repeat expansions and human hereditary disorders. Curr Opin Struct Biol 16:351-358.
32. Miyamoto T, Shiozawa T, Kashima H, Feng YZ, Suzuki A, Kurai M, Nikaido T, Konishi I. 2006. Estrogen up-regulates mismatch repair activity in normal and malignant endometrial glandular cells. Endocrinology 147:4863-4870.
33. Mollersen L, Rowe AD, Illuzzi JL, Hildrestrand GA, Gerhold KJ, Tveteras L, Bjolgerud A, Wilson DM, 3rd, Bjoras M, Klungland A. 2012. Neil1 is a genetic modifier of somatic and germline CAG trinucleotide repeat instability in R6/1 mice. Hum Mol Genet 21:4939-4947.
34. Mooney LA, Perera FP, Van Bennekum AM, Blaner WS, Karkoszka J, Covey L, Hsu Y, Cooper TB, Frenkel K. 2001. Gender differences in autoantibodies to oxidative DNA base damage in cigarette smokers. Cancer Epidemiol Biomarkers Prev 10:641-648.
35. Muftuoglu M, de Souza-Pinto NC, Dogan A, Aamann M, Stevnsner T, Rybanska I, Kirkali G, Dizdaroglu M, Bohr VA. 2009. Cockayne syndrome group B protein stimulates repair of formamidopyrimidines by NEIL1 DNA glycosylase. J Biol Chem 284:9270-9279.
36. Murdoch WJ, Van Kirk EA. 1997. Oestradiol inhibits spontaneous and cisplatin-induced apoptosis in epithelial ovarian cancer cells: relationship to DNA repair capacity. Apoptosis 2:478-484.
37. Murdoch WJ, Van Kirk EA. 2001. Estrogenic upregulation of DNA polymerase beta in oocytes of preovulatory ovine follicles. Mol Reprod Dev 58:417-423.
38. Newman JC, Bailey AD, Weiner AM. 2006. Cockayne syndrome group B protein (CSB) plays a general role in chromatin maintenance and remodeling. Proc Natl Acad Sci USA 103:9613-9618.
39. Oberle I, Rousseau F, Heitz D, Kretz C, Devys D, Hanauer A, Boue J, Bertheas M, Mandel J. 1991. Instability of a 550-base pair DNA segment and abnormal methylation in Fragile X syndrome. Science 252:1097-1102.
40. Orr HT, Zoghbi HY. 2007. Trinucleotide repeat disorders. Annu Rev Neurosci 30:575-621.
41. Pearson CE, Nichol Edamura K, Cleary JD. 2005. Repeat instability: mechanisms of dynamic mutations. Nat Rev Genet 6:729-742.
42. Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT, Nelson DL. 1991. Absence of expression of the FMR-1 gene in Fragile X syndrome. Cell 66:817-822.
43. Salinas-Rios V, Belotserkovskii BP, Hanawalt PC. 2011. DNA slip-outs cause RNA polymerase II arrest in vitro: potential implications for genetic instability. Nucleic Acids Res 39:7444-7454.
44. Schultz-Norton JR, Ziegler YS, Nardulli AM. 2011. ERalpha-associated protein networks. Trends Endocrinol Metab 22:124-129.
45. Selby CP, Sancar A. 1997. Cockayne syndrome group B protein enhances elongation by RNA polymerase II. Proc Natl Acad Sci USA 94:11205-11209.
46. Sherman SL. 2000. Premature ovarian failure in the Fragile X syndrome. Am J Med Genet 97:189-194.
47. Strom CM, Crossley B, Redman JB, Buller A, Quan F, Peng M, McGinnis M, Fenwick RG Jr., Sun W. 2007. Molecular testing for Fragile X syndrome: lessons learned from 119, 232 tests performed in a clinical laboratory. Genet Med 9:46-51.
48. Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey TE, Hagerman PJ. 2000. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the Fragile-X syndrome. Am J Hum Genet 66:6-15.
49. Taylor AK, Tassone F, Dyer PN, Hersch SM, Harris JB, Greenough WT, Hagerman RJ. 1999. Tissue heterogeneity of the FMR1 mutation in a high-functioning male with Fragile X syndrome. Am J Med Genet 84:233-239.
50. Tome S, Manley K, Simard JP, Clark GW, Slean MM, Swami M, Shelbourne PF, Tillier ER, Monckton DG, Messer A, Pearson CE. 2013. MSH3 polymorphisms and protein levels affect CAG repeat instability in Huntington's disease mice. PLoS Genet 9:e1003280.
51. Usdin K. 2008. The biological effects of simple tandem repeats: lessons from the repeat expansion diseases. Genome Res 18:1011-1019.
52. van der Horst GT, van Steeg H, Berg RJ, van Gool AJ, de Wit J, Weeda G, Morreau H, Beems RB, van Kreijl CF, de Gruijl FR, Bootsma D, Hoeijmakers JH. 1997. Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition. Cell 89:425-435.
53. Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang FP, Eussen BE, van Ommen GJB, et al. 1991. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-914.
54. Wheeler VC, Auerbach W, White JK, Srinidhi J, Auerbach A, Ryan A, Duyao MP, Vrbanac V, Weaver M, Gusella JF, Joyner AL, MacDonald ME. 1999. Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse. Hum Mol Genet 8:115-122.
55. Willemsen R, Levenga J, Oostra BA. 2011. CGG repeat in the FMR1 gene: size matters. Clin Genet 80:214-225.
56. Wohrle D, Salat U, Glaser D, Mucke J, Meisel-Stosiek M, Schindler D, Vogel W, Steinbach P. 1998. Unusual mutations in high functioning fragile X males: apparent instability of expanded unmethylated CGG repeats. J Med Genet 35:103-111.
57. Wohrle D, Salat U, Hameister H, Vogel W, Steinbach P. 2001. Demethylation, reactivation, and destabilization of human fragile X full-mutation alleles in mouse embryocarcinoma cells. Am J Hum Genet 69:504-515.
58. Wohrle D, Schwemmle S, Steinbach P. 1996. DNA methylation and triplet repeat stability: new proposals addressing actual questions on the CGG repeat of fragile X syndrome. Am J Med Genet 64:266-267.